An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer
Clinical trial NCT02015871 · COMPLETED
Trial details
- NCT number
- NCT02015871
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2017-08-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.